Web Desc
Immunological Intervention in Human Disease
Organizer(s): Jacques F. Banchereau, Federica Sallusto and Robert L. Coffman
Date: January 06 - 11, 2007
Location: Big Sky Resort, Big Sky, MT, USA
Sponsored by the Dana Foundation
Summary of Meeting:
Decades of intense cellular and molecular studies have permitted the identification of many components of the immune system. Studies of the mouse immune system, most particularly through the use of animals with targeted gene inactivation, have permitted remarkable progress in linking these components to specific functions in immunity. In spite of this progress, the study of the human immune system has in general lagged behind that of the mouse. Improvements in technologies, however, now permit a detailed analysis of the altered immune system in human diseases including cancer, allergy, autoimmunity, and infectious diseases. The meeting will emphasize 1) the importance of directly assessing the human immune response and 2) that not all of what we learn in the mouse can be directly translated to humans. To foster interactions between immunologists and pathologists from very different backgrounds, the meeting program includes a wide variety of experts investigating different human diseases that involve alterations of the immune system. Consequently, this meeting is highly likely to contribute to the education of a new generation of immunotherapists.
Scholarship Deadline: October 9 2006
Discounted Abstract Deadline: September 13 2006
Abstract Deadline: October 9 2006
Discounted Registration Deadline: November 6 2006
We gratefully acknowledge additional support for this conference from:
Burroughs Wellcome FundDana FoundationJDRFUCB Celltech
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Genentech, Inc.

Regeneron Pharmaceuticals, Inc.
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1 R13 AI071685-01
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program

Saturday, January 06 | 3:00PM - 7:30PM
Registration
Room: Lower Atrium


Saturday, January 06 | 6:30PM - 7:30PM
Refreshments
Room: Lower Atrium


Saturday, January 06 | 7:30PM - 8:30PM
Keynote Session
Room: Madison/Gallatin

Speaker 1 of 2
* Jacques F. Banchereau, The Jackson Laboratory for Genomic Medicine, USA

Saturday, January 06 | 7:30PM - 8:30PM
Keynote Session
Room: Madison/Gallatin

Speaker 2 of 2
Ralph M. Steinman, Rockefeller University, USA
Dendritic Cells in Medicine

Sunday, January 07 | 7:00AM - 8:00AM
Breakfast
Room: Jefferson


Sunday, January 07 | 8:00AM - 11:30AM
Human Immune Effectors and Pathways - I
Room: Madison/Gallatin

Speaker 1 of 7
* Jacques F. Banchereau, The Jackson Laboratory for Genomic Medicine, USA
Human Dendritic Cell Subsets

Sunday, January 07 | 8:00AM - 11:30AM
Human Immune Effectors and Pathways - I
Room: Madison/Gallatin

Speaker 2 of 7
Miriam Merad, Mount Sinai School of Medicine, USA
Short Talk: Harnessing Tissue Dendritic Cell Homeostasis for the Treatment of Graft Versus Host Disease

Sunday, January 07 | 8:00AM - 11:30AM
Human Immune Effectors and Pathways - I
Room: Madison/Gallatin

Speaker 3 of 7
Lewis L. Lanier, University of California, San Francisco, USA
NK Receptors and their Control of Innate Immunity

Sunday, January 07 | 8:00AM - 11:30AM
Human Immune Effectors and Pathways - I
Room: Madison/Gallatin

Speaker 4 of 7
Niklas K. Björkström, Karolinska Institute, Sweden
Short Talk: Fcgamma×RIII+ Effector CD8 T Cells with NK Cell-Like Functions Expand in Response to Chronic Viral Infections

Sunday, January 07 | 8:00AM - 11:30AM
Human Immune Effectors and Pathways - I
Room: Madison/Gallatin

Speaker 5 of 7
Albert S. Bendelac, University of Chicago, USA
Adjuvant Effects of NKT Ligands

Sunday, January 07 | 8:00AM - 11:30AM
Human Immune Effectors and Pathways - I
Room: Madison/Gallatin

Speaker 6 of 7
Vicki S. Stronge, STEMCELL Technologies Inc, Canada
Short Talk: Structural Insights into Glycolipid Loading by CD1d

Sunday, January 07 | 8:00AM - 11:30AM
Human Immune Effectors and Pathways - I
Room: Madison/Gallatin

Speaker 7 of 7
Antonio Lanzavecchia, Institute for Research in Biomedicine, Switzerland
Exploring and Exploiting Human B Cell Memory

Sunday, January 07 | 9:20AM - 9:40AM
Coffee Break
Room: Lower Atrium


Sunday, January 07 | 11:30AM - 1:00PM
Poster Setup
Room: Jefferson


Sunday, January 07 | 1:00PM - 10:00PM
Poster Viewing
Room: Jefferson


Sunday, January 07 | 2:00PM - 4:30PM
Workshop 1: Assessing Human Immunity
Room: Madison/Gallatin

Speaker 1 of 7
Roshini S. Abraham, Mayo Clinic, USA
Assessment of Thymic Reconstitution in the Clinical Laboratory Using TRECs as a Marker

Sunday, January 07 | 2:00PM - 4:30PM
Workshop 1: Assessing Human Immunity
Room: Madison/Gallatin

Speaker 2 of 7
Florence Allantaz Frager, Baylor Institute for Immunology Research, USA
Blood Leukocyte Microarray Analysis to Diagnose Systemic Onset Juvenile Idiopathic Arthritis and to follow response to IL-1 Blockade

Sunday, January 07 | 2:00PM - 4:30PM
Workshop 1: Assessing Human Immunity
Room: Madison/Gallatin

Speaker 3 of 7
Jonathan C. Choy, Simon Fraser University, Canada
Induction of iNOS in Bystander Human T Cells Increases Allogeneic Responses in the Vasculature

Sunday, January 07 | 2:00PM - 4:30PM
Workshop 1: Assessing Human Immunity
Room: Madison/Gallatin

Speaker 4 of 7
David R. Karp, University of Texas Southwestern Medical Center, USA
Analysis of Partial and Complete SLE Phenotypes Using Autoantigen Proteome Arrays

Sunday, January 07 | 2:00PM - 4:30PM
Workshop 1: Assessing Human Immunity
Room: Madison/Gallatin

Speaker 5 of 7
Rimpei Morita, Nippon Medical School, Japan
Follicular Helper T cells: Development and Function

Sunday, January 07 | 2:00PM - 4:30PM
Workshop 1: Assessing Human Immunity
Room: Madison/Gallatin

Speaker 6 of 7
Johan K. Sandberg, Karolinska Institute, Sweden
Impact of HCV/HIV-1 co-infection and Treatment with Pegylated IFNalpha and Ribavirin on NK Cells and the Innate CD1d-Restricted NKT Cells

Sunday, January 07 | 2:00PM - 4:30PM
Workshop 1: Assessing Human Immunity
Room: Madison/Gallatin

Speaker 7 of 7
Blythe D. Sather, Lyell Immunopharma, USA
Wiskott Aldrich Syndrome Protein is Required for Regulatory T Cell Homeostasis



Sunday, January 07 | 4:30PM - 4:45PM
Coffee Available
Room: Lower Atrium


Sunday, January 07 | 4:45PM - 7:00PM
Human Immune Effectors and Pathways - II
Room: Madison/Gallatin

Speaker 1 of 5
* Federica Sallusto, Università della Svizzera Italiana & ETH Zurich, Switzerland
T Cell Subsets in Disease

Sunday, January 07 | 4:45PM - 7:00PM
Human Immune Effectors and Pathways - II
Room: Madison/Gallatin

Speaker 2 of 5
Christine M. Rohowsky-Kochan, University of Medicine and Dentistry of New Jersey, USA
Short Talk: IL-6 and IL-23 are Critical Factors in the Generation of Human Th17-Secreting T Cells

Sunday, January 07 | 4:45PM - 7:00PM
Human Immune Effectors and Pathways - II
Room: Madison/Gallatin

Speaker 3 of 5
Rene de Waal Malefyt, Merck Research Labs, USA
Short Talk: IL-23-Derived Human Th17 Cells Produce IL-17A, IL-17F,
IL-22, IL-26, CCL20 and Enhance Epithelial Immunity


Sunday, January 07 | 4:45PM - 7:00PM
Human Immune Effectors and Pathways - II
Room: Madison/Gallatin

Speaker 4 of 5
Yong-Jun Liu, Sanofi, USA
Plasmacytoid Dendritic Cells

Sunday, January 07 | 4:45PM - 7:00PM
Human Immune Effectors and Pathways - II
Room: Madison/Gallatin

Speaker 5 of 5
Jean-Laurent Casanova, Rockefeller University, USA
A Genetic Dissection of Cytokine-Mediated Immunity to Infection in Humans

Sunday, January 07 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Jefferson


Sunday, January 07 | 7:30PM - 10:00PM
Poster Session 1
Room: Jefferson


Monday, January 08 | 7:00AM - 8:00AM
Breakfast
Room: Jefferson


Monday, January 08 | 8:00AM - 11:30AM
Immune Regulation and Autoimmunity - I
Room: Madison/Gallatin

Speaker 1 of 6
* Jeffrey V. Ravetch, Rockefeller University, USA
Inhibitory and Stimulatory Fcgamma Receptors

Monday, January 08 | 8:00AM - 11:30AM
Immune Regulation and Autoimmunity - I
Room: Madison/Gallatin

Speaker 2 of 6
Silvia Gregori, San Raffaele Telethon Institute for Gene Therapy, Italy
Novel Approaches to Expand/Induce Regulatory T Cells

Monday, January 08 | 8:00AM - 11:30AM
Immune Regulation and Autoimmunity - I
Room: Madison/Gallatin

Speaker 3 of 6
Catherine M. Hawrylowicz, King's College London, UK
Short Talk: TLR9 is Expressed by Human Drug-Induced IL-10 Secreting Treg and Ligation Modulates Function

Monday, January 08 | 8:00AM - 11:30AM
Immune Regulation and Autoimmunity - I
Room: Madison/Gallatin

Speaker 4 of 6
Jeffrey A. Bluestone, University of California, San Francisco, USA
Human Regulatory T Cells

Monday, January 08 | 8:00AM - 11:30AM
Immune Regulation and Autoimmunity - I
Room: Madison/Gallatin

Speaker 5 of 6
Brian M. J. Foxwell, Imperial College, UK
A Role for TRL Signaling in Driving Inflammation in RA

Monday, January 08 | 8:00AM - 11:30AM
Immune Regulation and Autoimmunity - I
Room: Madison/Gallatin

Speaker 6 of 6
Mark Larché, McMaster University, Canada
Peptide-Based Therapeutic Vaccines for Allergic and Autoimmune Diseases

Monday, January 08 | 9:20AM - 9:40AM
Coffee Break
Room: Lower Atrium


Monday, January 08 | 11:00AM - 1:00PM
Poster Setup
Room: Jefferson


Monday, January 08 | 1:00PM - 10:00PM
Poster Viewing
Room: Jefferson


Monday, January 08 | 2:00PM - 4:30PM
Workshop 2: Improving Human Vaccines
Room: Madison/Gallatin

Speaker 1 of 8
Anthony Byers, Sanofi Pasteur, USA
Vaccine Testing Potential of an in vitro Human Tissue Model

Monday, January 08 | 2:00PM - 4:30PM
Workshop 2: Improving Human Vaccines
Room: Madison/Gallatin

Speaker 2 of 8
David M. Calderhead, Argos Therapeutics, USA
Development of Superior DC Co-Transfected with RNAs Encoding Antigen and CD40L that Induce Clinically Relevant CD4 Independent CD8 CTL

Monday, January 08 | 2:00PM - 4:30PM
Workshop 2: Improving Human Vaccines
Room: Madison/Gallatin

Speaker 3 of 8
Mark DeBenedette, Argos Therapeutics, USA
PME-CD40L DC Prime the Expansion of CD28+/CD45RA- Long Lived Effector Memory CTL Having Clinical Relevance for Dendritic Cell Based Immunotherapies

Monday, January 08 | 2:00PM - 4:30PM
Workshop 2: Improving Human Vaccines
Room: Madison/Gallatin

Speaker 4 of 8
Albert B. Deisseroth, Sidney Kimmel Cancer Center, USA
Vector Vaccine for Cancer and Infectious Diseases

Monday, January 08 | 2:00PM - 4:30PM
Workshop 2: Improving Human Vaccines
Room: Madison/Gallatin

Speaker 5 of 8
Larry R. Pease, Mayo Clinic, USA
Modulation of Immune Polarity and Activation of Antigen-Specific CTL with a Human IgM Antibody that Cross-Links B7-DC

Monday, January 08 | 2:00PM - 4:30PM
Workshop 2: Improving Human Vaccines
Room: Madison/Gallatin

Speaker 6 of 8
Georg Stary, Harvard Medical School, USA
TLR7/8-Activated Inflammatory Denditic CEells as Anti-Cancer Effector Cells

Monday, January 08 | 2:00PM - 4:30PM
Workshop 2: Improving Human Vaccines
Room: Madison/Gallatin

Speaker 7 of 8
Chun I. Yu, Baylor Research Institute, USA
Humice to test efficacy of vaccines against Influenza virus

Monday, January 08 | 2:00PM - 4:30PM
Workshop 2: Improving Human Vaccines
Room: Madison/Gallatin

Speaker 8 of 8
* Robert A. Seder, NIAID, National Institutes of Health, USA
TLR Ligands Influence the Quality of T Cell Responses

Monday, January 08 | 4:30PM - 4:45PM
Coffee Available
Room: Lower Atrium


Monday, January 08 | 5:00PM - 7:00PM
Immune Regulation and Autoimmunity - II
Room: Madison/Gallatin

Speaker 1 of 4
Jürg Tschopp, University of Lausanne, Switzerland
The Inflammasome: A Danger Signal Sensing Complex Involved in Autoinflammatory Diseases

Monday, January 08 | 5:00PM - 7:00PM
Immune Regulation and Autoimmunity - II
Room: Madison/Gallatin

Speaker 2 of 4
* Virginia Pascual, Cornell University, USA
IFNa and IL1 in Human Autoimmunity

Monday, January 08 | 5:00PM - 7:00PM
Immune Regulation and Autoimmunity - II
Room: Madison/Gallatin

Speaker 3 of 4
Michel Gilliet, University Hospital of Lausanne, Switzerland
Short Talk: Innate Activation of Plasmacytoid DC by an Endogenous Peptide

Monday, January 08 | 5:00PM - 7:00PM
Immune Regulation and Autoimmunity - II
Room: Madison/Gallatin

Speaker 4 of 4
Cornelia M. Weyand, Stanford University, USA
Toll-like Receptors in Large Vessel Vasculitis

Monday, January 08 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Jefferson


Monday, January 08 | 7:30PM - 10:00PM
Poster Session 2
Room: Jefferson


Tuesday, January 09 | 7:00AM - 8:00AM
Breakfast
Room: Jefferson


Tuesday, January 09 | 8:00AM - 11:15AM
Innovations in Cancer I
Room: Madison/Gallatin

Speaker 1 of 6
Louis M. Staudt, NCI, National Institutes of Health, USA
Gene Expression Signatures of the Immune Response to Guide the Diagnosis, Prognosis and Treatment of Cancer

Tuesday, January 09 | 8:00AM - 11:15AM
Innovations in Cancer I
Room: Madison/Gallatin

Speaker 2 of 6
Andrew C. Chan, Genentech, Inc., USA
Targeting B Cells in Cancer and Autoimmunity

Tuesday, January 09 | 8:00AM - 11:15AM
Innovations in Cancer I
Room: Madison/Gallatin

Speaker 3 of 6
Bretton C. Summers, Genentech, USA
Short Talk: CXCR7 (RDC1) Directly Regulates Breast and Lung Cancer

Tuesday, January 09 | 8:00AM - 11:15AM
Innovations in Cancer I
Room: Madison/Gallatin

Speaker 4 of 6
* Laurence Zitvogel, Institut Gustave Roussy, France
Molecular Determinants of the Immunogenicity of Cell Death: Designing Tumor Vaccines with Apoptosis Inducers

Tuesday, January 09 | 8:00AM - 11:15AM
Innovations in Cancer I
Room: Madison/Gallatin

Speaker 5 of 6
Hideki Ueno, Icahn School of Medicine at Mount Sinai, USA
Short Talk: Circulating Tumor-Associated Antigen Specific Regulatory CD4+ T Cells in Patients with Metastatic Melanoma

Tuesday, January 09 | 8:00AM - 11:15AM
Innovations in Cancer I
Room: Madison/Gallatin

Speaker 6 of 6
Philip D. Greenberg, University of Washington, USA
Adoptive T Cell Therapy of Cancer and Viral Diseases

Tuesday, January 09 | 9:20AM - 9:40AM
Coffee Break
Room: Lower Atrium


Tuesday, January 09 | 11:15AM - 1:00PM
Poster Setup
Room: Jefferson


Tuesday, January 09 | 1:00PM - 10:00PM
Poster Viewing
Room: Jefferson


Tuesday, January 09 | 4:30PM - 4:45PM
Coffee Available
Room: Lower Atrium


Tuesday, January 09 | 4:45PM - 7:00PM
Innovations in Cancer II
Room: Madison/Gallatin

Speaker 1 of 4
* Olivera J. Finn, University of Pittsburgh School of Medicine, USA
Targeting MUC1 to Prevent Cancer

Tuesday, January 09 | 4:45PM - 7:00PM
Innovations in Cancer II
Room: Madison/Gallatin

Speaker 2 of 4
Dean L. Mann, University of Maryland Medical School, USA
Short Talk: Studies on the Safety of Intra-Tumoral Injuction of Autologous Dendritic Cell and Activated T Cells Combined With Conventional Therapies in Patients with Advanced Cancers

Tuesday, January 09 | 4:45PM - 7:00PM
Innovations in Cancer II
Room: Madison/Gallatin

Speaker 3 of 4
Madhav V. Dhodapkar, Yale School of Medicine, USA
Probing Immune Response to Human Premalignancy

Tuesday, January 09 | 4:45PM - 7:00PM
Innovations in Cancer II
Room: Madison/Gallatin

Speaker 4 of 4
Ronald Levy, Stanford University, USA
Lymphoma Vaccines

Tuesday, January 09 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Jefferson


Tuesday, January 09 | 7:30PM - 10:00PM
Poster Session 3
Room: Jefferson


Wednesday, January 10 | 7:00AM - 8:00AM
Breakfast
Room: Jefferson


Wednesday, January 10 | 8:00AM - 11:00AM
Innovations in Human Infections
Room: Madison/Gallatin

Speaker 1 of 6
* Richard A. Koup, NIAID, National Institutes of Health, USA
Prime-Boost Vaccination Against HIV Infection

Wednesday, January 10 | 8:00AM - 11:00AM
Innovations in Human Infections
Room: Madison/Gallatin

Speaker 2 of 6
Rafick Sekaly, Emory University, USA
Reconstituting the HIV Specific Immune Response

Wednesday, January 10 | 8:00AM - 11:00AM
Innovations in Human Infections
Room: Madison/Gallatin

Speaker 3 of 6
Erika Adriana Eksioglu, H. Lee Moffitt Cancer Center, USA
Short Talk: Dendritic Cell Response to Hepatitis C Virus

Wednesday, January 10 | 8:00AM - 11:00AM
Innovations in Human Infections
Room: Madison/Gallatin

Speaker 4 of 6
Jay K. Kolls, Tulane School of Medicine, USA
IL-17 Family Members

Wednesday, January 10 | 8:00AM - 11:00AM
Innovations in Human Infections
Room: Madison/Gallatin

Speaker 5 of 6
Susanne I. S. Nylén-Spoomaker, NIAID, National Institutes of Health, USA
Short Talk: Human Visceral Leishmaniasis is Associated with IL-10 Producing T Cells that are Distinct from CD4+CD25+ (Foxp3) Regulatory T Cells

Wednesday, January 10 | 8:00AM - 11:00AM
Innovations in Human Infections
Room: Madison/Gallatin

Speaker 6 of 6
Kevin J. Tracey, Feinstein Institute for Medical Research, USA
The Inflammatory Reflex

Wednesday, January 10 | 9:20AM - 9:40AM
Coffee Break
Room: Lower Atrium


Wednesday, January 10 | 2:00PM - 4:30PM
Workshop 3: Improving Autoimmunity and Allergy
Room: Madison/Gallatin

Speaker 1 of 9
* Robert L. Coffman, Dynavax Technologies, USA
Development of TLR7/9 Antaganoists for SLE

Wednesday, January 10 | 2:00PM - 4:30PM
Workshop 3: Improving Autoimmunity and Allergy
Room: Madison/Gallatin

Speaker 2 of 9
Ilan Bank, Tel Aviv University, Israel
alpha1beta1 Integrin+ and Regulatory Foxp3+ T Cells Constitute Two Functionally Distinct Human CD4+ T Cell Subsets Oppositely Modulated by TNFalpha Blockade

Wednesday, January 10 | 2:00PM - 4:30PM
Workshop 3: Improving Autoimmunity and Allergy
Room: Madison/Gallatin

Speaker 3 of 9
Alma-Martina Cepika, Stanford School of Medicine, USA
Toll-Like Receptors and Regulatory T Cells in Systemic Lupus Erythematosus

Wednesday, January 10 | 2:00PM - 4:30PM
Workshop 3: Improving Autoimmunity and Allergy
Room: Madison/Gallatin

Speaker 4 of 9
Grayson B. Lipford, Janus Biotherapeutics, Inc., USA
A Selective Toll-like Receptor 7/8/9 Antagonist for the Oral Treatment of Systemic Lupus Erythematosus

Wednesday, January 10 | 2:00PM - 4:30PM
Workshop 3: Improving Autoimmunity and Allergy
Room: Madison/Gallatin

Speaker 5 of 9
Nicola M. G. Smith, University of Oxford, UK
Defining an Effector T Cell Population in a Surrogate Model for RA

Wednesday, January 10 | 2:00PM - 4:30PM
Workshop 3: Improving Autoimmunity and Allergy
Room: Madison/Gallatin

Speaker 6 of 9
Horst von Bernuth, University V René Descartes, France
Human MyD88 Deficiency : A Novel Primary Immunodeficiency

Wednesday, January 10 | 2:00PM - 4:30PM
Workshop 3: Improving Autoimmunity and Allergy
Room: Madison/Gallatin

Speaker 7 of 9
Matthew J. Walters, ChemoCentryx, USA
Pharmacological Inhibition of Gut Homing CCR9 T-cells Alters Disease Severity in Murine Models of Inflammatory Bowel Disease

Wednesday, January 10 | 2:00PM - 4:30PM
Workshop 3: Improving Autoimmunity and Allergy
Room: Madison/Gallatin

Speaker 8 of 9
Kazuyuki Yoshizaki, Osaka University, Japan
Immunological Intervention in Rheumatoid Arthritis by the Blocking of Interleukin 6 a Single Cytokine

Wednesday, January 10 | 2:00PM - 4:30PM
Workshop 3: Improving Autoimmunity and Allergy
Room: Madison/Gallatin

Speaker 9 of 9
Chunfeng Qu, Cancer Institute/Hospital, Chinese Academy of Medical Sciences, China
Maturation and Cross-Presentation by Human Monocyte-Derived Cells After Uptake of Apoptotic Flu-Infected or Poly-IC-Loaded Autologous Cells

Wednesday, January 10 | 4:30PM - 4:45PM
Coffee Available
Room: Lower Atrium


Wednesday, January 10 | 4:45PM - 7:30PM
Humanized Mouse Models
Room: Madison/Gallatin

Speaker 1 of 5
* A. Karolina Palucka, The Jackson Laboratory for Genomic Medicine, USA
Understanding the Interplay of the Human Immune System with Cancer in Immunodeficient Mice

Wednesday, January 10 | 4:45PM - 7:30PM
Humanized Mouse Models
Room: Madison/Gallatin

Speaker 2 of 5
Sean M. Stevens, Regeneron Pharmaceuticals Inc., USA
VelocImmune: Mice with Genetically Humanized Immune Systems, Constructed via VelociGene Technology

Wednesday, January 10 | 4:45PM - 7:30PM
Humanized Mouse Models
Room: Madison/Gallatin

Speaker 3 of 5
Markus G. Manz, University Hospital Zürich, Switzerland
Human Adaptive Immune System Rag2-/-gammac-/-Mice: Opportunities and Limitations

Wednesday, January 10 | 4:45PM - 7:30PM
Humanized Mouse Models
Room: Madison/Gallatin

Speaker 4 of 5
Frank Oliver Nestle, Sanofi, USA
Short Talk: Insights From a Humanized Mouse Model of Psoriasis Define a Novel Epithelial Homing Effector T Cell Population

Wednesday, January 10 | 4:45PM - 7:30PM
Humanized Mouse Models
Room: Madison/Gallatin

Speaker 5 of 5
Hergen Spits, University of Amsterdam, Netherlands
Construction of Human Immune System in Mice

Wednesday, January 10 | 7:30PM - 8:30PM
Social Hour with Lite Bites
Room: Jefferson/Madison


Wednesday, January 10 | 8:00PM - 11:00PM
Entertainment
Room: Jefferson/Madison


Wednesday, January 10 | 8:00PM - 11:00PM
Cash Bar
Room: Jefferson/Madison


Thursday, January 11 | 10:26AM - 10:26AM
Departure


*Session Chair.